OMRF Multiple Sclerosis Center of Excellence

Oklahoma City, Oklahoma 73104

1 studies enrolling now · 5 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis — Recruiting now
• An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab — Completed
• Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex — Completed
• An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS) — Completed
• Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis — Completed